Jan.-June 2025 | 1,197 |
2024 | 285 |
2023 | 59 |
Average 2000-2024 | 178 |
2000 | 86 |
1990 | 27,786 |
1970 | 47,351 |
1960 | 441,703 |
Measles is an exceptionally “transmissible” disease — one infected person will typically pass it to 12-18 more — and survivors often suffer long-term immune system damage and a heightened risk of early dementia. In the 1950s, American health statistics typically showed about half a million cases and 500 deaths a year. The 1964 introduction of measles vaccines produced by Merck and Pfizer cut this by 90% — to 47,351 — by 1970, and to an average below 200 per year since 2000. That can make people complacent — and then near-vanished diseases can return. This year’s measles epidemic, centered in a low-vaccination Texas county, has already hospitalized 112 people and killed three. As long-time anti-vaccination crank Robert F. Kennedy Jr. purges immunization experts at the Department of Health and Human Services, and the Trump administration asks Congress to cancel U.S. contributions to GAVI (the international consortium providing 70 million no-cost vaccinations in low-income countries annually), some background on vaccines, malgovernance, and the possible future:
Vaccines are classes of medicine offering advance protection from 25 contagious diseases — smallpox, typhoid, hepatitis A and hepatitis B, tetanus, diphtheria, polio, measles, rabies, cholera, and encephalitis — borne by viruses or bacteria. The mRNA vaccine for COVID-19 is the most recent. Vaccines come into use in the United States after a scientific evaluation, formal government approval, and finally recommendations for use by medical professionals. Both here and worldwide, they have made life safer, longer, and better. For example:
Poliomyelitis: In the 1940s and 1950s, before the introduction of the Salk vaccine, America’s annual polio counts often topped 57,000 cases and 3,000 deaths. Since 1993, we have had one case, an unvaccinated man returning from abroad. Overseas, though some “wild” strains remain endemic in Afghanistan and Pakistan, universal vaccination programs run by the World Health Organization, USAID, the CDC, charities, and national health ministries have cut case levels by 99.99%. The numbers:
2024 96 polio cases
2020 6 polio cases
2010 650 polio cases
2000 3,500 polio cases
1988 350,000 polio cases
Neo-natal tetanus data are similar: U.S. case rates have dropped from about 500 a year in the 1950s to 30 or so since 2000. Abroad, campaigns to vaccinate pregnant women and guarantee antiseptic standards in poor-country maternity clinics have cut deaths by about 99%, from nearly a million to fewer than 10,000 annually.
2021 7,719 tetanus deaths
2018 25,000 tetanus deaths
2000 309,000 tetanus deaths
1988 787,000 tetanus deaths
To place these specific cases in wider perspective, worldwide vaccination campaigns such as those run by GAVI – which spends a modest $1.7 billion a year, with America providing $300 million of it, to vaccinate 70 million children in 59 developing countries — have joined with the invention of new treatments and improving primary care to cut world under-five mortality rates by half since 2000 and nearly three-quarters in a generation.
2023 | 37 deaths per 1000 children |
2020 | 39 deaths per 1000 children |
2010 | 53 deaths per 1000 children |
2000 | 77 deaths per 1000 children |
1990 | 94 deaths per 1000 children |
1980 | 132 deaths per 1000 children |
World Health Organization for 1990-2023; World Bank World Development Indicators for 1980.
In sum, vaccine work — by scientists in government and private-sector labs, by businesses inventing and producing medicines, by charities and international organizations, by nurses and doctors, and by clinics and hospitals — has vastly reduced disease case counts, saved many lives, and given young children better chances in life. The achievement may have been so impressive, in fact, as to encourage a dangerous complacency.
This year’s measles outbreak is a vivid example. The Centers for Disease Control notes that since 2020, America’s rate of “MMR” vaccination (the “measles, mumps, and rubella” combined shot) has fallen from 93.9% to 91.3% — that is, below the level thought necessary for the “herd immunity” which helps protect immune-suppressed people. Gaines County in Texas, the center of this year’s measles outbreak, has an especially low 83.7% rate. CDC’s count shows that within a few months, it has already infected 1197 people (including 347 children under 5, and 446 older children and teenagers), and will likely be the largest outbreak in three decades. The three people who died of it were all unvaccinated.
After decades of safety, then, Americans may be unwisely discounting disease risk and giving cranks and self-taught “contrarians” audiences they don’t deserve. The same may be true internationally. Worldwide measles deaths, having dropped by 92% from 1980 to 2020, have recently risen as global vaccination rates have slipped from 86% of children in 2020 to 83% in 2023.
2023 | 107,500 deaths |
2020 | 69,400 deaths |
2010 | 203,000 deaths |
2000 | 525,000 deaths |
1980 | 810,000 deaths |
Which brings us back to the Trump administration, this month’s ominous events at HHS, and Congress’ debate over health-aid “rescissions” this week.
Mr. Kennedy’s tragi-comic launch event — a “report” on children’s health apparently compiled by an AI program, stocked with invented quotes and cites to non-existent studies — has been followed by steadily escalating attempts to erode vaccination policy at home. Since May, Mr. Kennedy has canceled support for the development of second-generation mRNA vaccines and bypassed CDC professionals to remove scientific recommendations for COVID-19 vaccination updates; and, two weeks ago, fired the 17 members of the CDC’s voluntary expert advisory group, the Advisory Committee on Immunization Practices, a few weeks before their regular June meeting. The extraordinary op-ed (subs. req.) he used to announce this justifies the decision with (a) fact-free innuendo about “conflicts of interest” among the current ACIP members, without any specific claim to back it up, and (b) an open admission that the administration sees ACIP positions less as sources of impartial analysis than as patronage. (“[W]ithout removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028”.) The American Medical Association’s comment:
“For generations, the Advisory Committee on Immunization Practices (ACIP) has been a trusted national source of science-and data-driven advice and guidance on the use of vaccines to prevent and control disease. Physicians, parents, community leaders and public health officials rely on them for clinical guidance, public health information, and knowledge. Today’s action to remove the 17 sitting members of ACIP undermines that trust and upends a transparent process that has saved countless lives. With an ongoing measles outbreak and routine child vaccination rates declining, this move will further fuel the spread of vaccine-preventable illnesses.”
The administration is matching this malgovernance abroad. Their “rescissions” bill cancels the entire U.S. contribution to GAVI, along with hundreds of millions of dollars meant for child and maternal health, HIV/AIDS, and other public health programs. (Sample justification, direct quote: “programs that are antithetical to American interests and worsen the lives of women and children, like ‘family planning’ and ‘reproductive health.’”) If the Senate approves it, the U.S.’ commitment to vaccination abroad will shrivel to pretty much nothing.
Both at home and abroad, then, public complacency has grown and government policy deteriorated. If the approach of the administration’s first five months persists, the next three years may be somber: an era in which long-vanished diseases return in force to America, children’s health erodes here and abroad, and life grows more dangerous. Congress, we hope, is aware that the right approach is diametrically opposite. Again, vaccines have made life longer, safer and better. We need more of them, not less.
PPI’s four principles for response to tariffs and economic isolationism:
The return of measles:
CDC on this year’s measles outbreak.
The American Academy of Pediatrics has a state-by-state map comparing vaccination rates.
And a Texas case count by county, from Texas’ Department of Health Services.
At HHS:
2024 membership for the Advisory Committee on Immunization Practices (ACIP).
Mr. Kennedy’s “Children’s Health Report” fiasco.
… and op-ed on ACIP.
Responses:
Alarmed comment from the American Public Health Association.
… likewise from the American Medical Association.
… and the American Academy of Pediatrics.
Abroad:
White House “rescissions” justifications.
Background and annual reports from GAVI, the Vaccine Alliance.
From the Kaiser Family Foundation, a review of U.S. global health budgeting.
… and a close-up on the Trump administration and GAVI.
From the World Health Organization, recommendations on vaccines.
… an update on measles trends.
… and data on under-5 mortality:
And a PPI flashback:
Ed Gresser testifies in June 2023 to the House Judiciary Committee’s Intellectual Property Subcommittee on WTO intellectual property rules, vaccine production, and the response to the COVID-19 pandemic.
Ed Gresser is Vice President and Director for Trade and Global Markets at PPI.
Ed returns to PPI after working for the think tank from 2001-2011. He most recently served as the Assistant U.S. Trade Representative for Trade Policy and Economics at the Office of the United States Trade Representative (USTR). In this position, he led USTR’s economic research unit from 2015-2021, and chaired the 21-agency Trade Policy Staff Committee.
Ed began his career on Capitol Hill before serving USTR as Policy Advisor to USTR Charlene Barshefsky from 1998 to 2001. He then led PPI’s Trade and Global Markets Project from 2001 to 2011. After PPI, he co-founded and directed the independent think tank Progressive Economy until rejoining USTR in 2015. In 2013, the Washington International Trade Association presented him with its Lighthouse Award, awarded annually to an individual or group for significant contributions to trade policy.
Ed is the author of Freedom from Want: American Liberalism and the Global Economy (2007). He has published in a variety of journals and newspapers, and his research has been cited by leading academics and international organizations including the WTO, World Bank, and International Monetary Fund. He is a graduate of Stanford University and holds a Master’s Degree in International Affairs from Columbia Universities and a certificate from the Averell Harriman Institute for Advanced Study of the Soviet Union.